JPH0778502B2 - Method for preserving cells in urine - Google Patents

Method for preserving cells in urine

Info

Publication number
JPH0778502B2
JPH0778502B2 JP2090638A JP9063890A JPH0778502B2 JP H0778502 B2 JPH0778502 B2 JP H0778502B2 JP 2090638 A JP2090638 A JP 2090638A JP 9063890 A JP9063890 A JP 9063890A JP H0778502 B2 JPH0778502 B2 JP H0778502B2
Authority
JP
Japan
Prior art keywords
urine
cells
acid
sample
citric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2090638A
Other languages
Japanese (ja)
Other versions
JPH04118557A (en
Inventor
壱夫 内田
浩 菊池
Original Assignee
株式会社京都医科学研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社京都医科学研究所 filed Critical 株式会社京都医科学研究所
Priority to JP2090638A priority Critical patent/JPH0778502B2/en
Publication of JPH04118557A publication Critical patent/JPH04118557A/en
Publication of JPH0778502B2 publication Critical patent/JPH0778502B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【発明の詳細な説明】 「産業上の利用分野」 この発明は尿中に剥離或いは漏出した細胞を計測,診断
する際に採尿後の尿中細胞の量,質の変化を防止して正
確な計測値,診断を得るための方法に関するものであ
る。
DETAILED DESCRIPTION OF THE INVENTION "Industrial field of application" The present invention provides accurate measurement by preventing changes in the amount and quality of urinary cells after urine collection when measuring and diagnosing detached or leaked cells in urine. It relates to methods for obtaining measured values and diagnoses.

「従来技術」 尿中に排出される生体細胞は腎臓,尿路系の疾患を診断
する上で非常に重要な臨床検査対象であり,また尿路系
悪性腫瘍のスクリーニング検査として広く用いられてい
る。この検査は逐次に採取した尿試料(逐次尿)或いは
一日の尿を蓄積した試料(蓄尿)等の中の細胞の量を計
測し,或いは該細胞を顕微鏡で観察して悪性か否かを判
定,診断(細胞診)するものである。
“Prior art” Urine excreted in urine is a very important clinical test target for diagnosing renal and urinary tract diseases, and is widely used as a screening test for malignant urinary tract tumors. . This test measures the amount of cells in a urine sample collected sequentially (sequential urine) or a sample that accumulates urine of one day (urine collection), or observes the cells with a microscope to determine whether they are malignant. Judgment and diagnosis (cytology) are performed.

ところで採尿後尿をそのまま室温で放置すると尿中の細
胞は低栄養状態に至り栄養を補給するために自己消化
(自己融解)を起こして変質(変性)し,或いは尿に含
まれる細菌によて破壊されて細胞数の減少と細胞の変性
が生ずることは良く知られている。そしてこの変性が生
ずると細胞診の際の判定が困難になる。
By the way, if the urine after collecting urine is left at room temperature as it is, the cells in the urine become undernourished and undergo autolysis (autolysis) to replenish the nutrients and are altered (denatured), or by the bacteria contained in the urine. It is well known that destruction causes a decrease in cell number and degeneration of cells. When this degeneration occurs, it becomes difficult to make a judgment at the time of cytodiagnosis.

この判定のしやすさの程度を以下のような基準で判定度
数として示すことが行われている。
The degree of ease of this determination is shown as the determination frequency based on the following criteria.

1.変性が強く細胞診上判定できない 2.変性がやや強く判定しにくい 3.変性はあるが判定可能 4.変性少なく判定可能 5.変性無く判定可能 本発明者らの実験によっても25℃で保存した尿では細胞
数は12時間後に30個/1視野から10個/1視野まで減少し,
また細胞診の判定度数は3以下に低下した。その場合診
断した細胞の殆どは変性しており,細胞中には食作用空
泡がかなり広がっているのが認められた。一般に逐次尿
を採取した後計測,診断を行うまでに,場合にもよるが
十数時間,蓄尿の場合には蓄尿開始から二十数時間の時
間があり,従って細胞数の減少および変性を防止する必
要があることは明らかである。
1. Deterioration is too strong to be judged by cytodiagnosis 2. Deterioration is rather strong and difficult to judge 3. Degeneration is possible, but it can be judged 4. Degeneration is small, judgment is possible 5. Degradation can be judged at 25 ° C even by the inventors' experiments The number of cells in the stored urine decreased from 30 cells / field to 10 cells / field after 12 hours,
The frequency of cytodiagnosis was reduced to 3 or less. In that case, most of the diagnosed cells were denatured, and phagocytic air bubbles were found to spread considerably in the cells. Generally, it takes tens of hours, depending on the case, and twentieth hours from the start of urine collection, depending on the case, until the measurement and diagnosis are performed after successive urine collections, thus preventing the decrease and degeneration of cell number. It is clear that there is a need.

従来からこの細胞数の減少および変性を阻止するため
に,逐次尿においては (1)採尿直後に遠心分離を行い,残サに固定液として
ホルムアルデヒドまたはグルタードアルデヒド等を加え
る (2)採尿直後に低温室に入れて低温に保持する 蓄尿においては長時間保存のため防腐剤として (1)トルエンまたはキシロールを2〜3ml/を加え,
時々震盪混和する (2)中性ホルマリンを5〜10ml/加える (3)クロルヘキシジンの5%溶液を5ml/加える (4)市販のほう酸またはパラホルムアルデヒド錠剤を
加える (5)低温室に入れて低温に保持する 等の方法が考えられている。しかし逐次尿,蓄尿とも
に,いずれの方法も採尿直後の作業や試料の輸送,保存
が厄介であるとの理由から実際には用いられていない。
In order to prevent this decrease in cell number and degeneration, in conventional urine, (1) Centrifuge immediately after urine collection, and add formaldehyde or glutardaldehyde as a fixative to the residue (2) Immediately after urine collection. Put it in a low greenhouse and keep it at low temperature For long-term storage in urine, as a preservative (1) Add 2-3 ml / of toluene or xylol,
Mix occasionally with shaking (2) Add 5-10 ml / neutral formalin (3) Add 5 ml / 5% chlorhexidine solution (4) Add commercially available boric acid or paraformaldehyde tablets (5) Put in low temperature room and cool Methods such as holding are considered. However, neither sequential urine collection nor actual urine collection is actually used because the work immediately after urine collection and the transportation and storage of samples are troublesome.

特に逐次尿に対する(1)の方法,蓄尿に対する(1)
〜(4)の方法では人体に対し非常に危険性の高い強毒
性物質を用いねばならない。また逐次尿の(1)の方法
では計測には耐えられるが,診断では判定しにくい欠点
があり,蓄尿の場合の(1)〜(4)では防腐作用とし
て尿中の細菌の繁殖を抑制するだけであって細胞の自己
消化を抑制することはできない。
In particular, (1) method for sequential urine, (1) for urine collection
In the method (4), a highly toxic substance that is extremely dangerous to the human body must be used. In addition, although the method (1) of sequential urine can withstand measurement, it has a drawback that it is difficult to determine by diagnosis. In cases (1) to (4) of storing urine, it suppresses bacterial growth in urine as an antiseptic action. However, it cannot suppress the autolysis of cells.

「発明が解決しようとする課題」 尿中の生体細胞が破壊,変性する原因は次ぎの2つであ
る。即ち1つには生体から剥離または漏出した細胞は代
謝作用を継続して行っており,低栄養時に細胞内の食作
用空泡で自己を消化して代謝に必要な栄養補給を行い,
やがて自己融解すること,2つには尿中に常在または病的
に存在する細菌が繁殖して細胞に直接付着またはその毒
素により生体細胞を破壊することである。
"Problems to be solved by the invention" There are the following two causes of destruction and degeneration of living cells in urine. That is to say, one is that cells that have been exfoliated or leaked from the living body continue to carry out metabolic action, and at the time of undernutrition, digest the self with intracellular phagocytic bubbles and supply the nutrients necessary for metabolism.
Eventually, it is autolyzed, and secondly, bacteria that are resident or pathologically present in urine propagate and directly attach to cells or destroy living cells by their toxins.

現状では,この両方の作用を防止し,且つ厄介な手間を
掛けず,安全である保存方法がないという課題がある。
At present, there is a problem that there is no safe storage method that prevents both of these actions, does not cause troublesome labor.

「課題を解決するための手段」 このような実情に鑑み本発明者らは従来の尿中の細胞保
存方法の欠点を解消すべく鋭意研究の結果,尿中のpHを
酸性に保持すると細胞の代謝が抑制されて自己消化が抑
制され,又細菌の繁殖,代謝も同時に抑制することがで
きることを見出した。さらにEDTA・2Na(エチレンジア
ミンテトラアセチックアシド2ナトリウム塩)を加える
とその抗菌効果により尿中に含まれる場合が多いグラム
陰性細菌の代謝及び増殖が大幅に抑制されることを発見
して本発明をなしたものである。
“Means for Solving the Problems” In view of such circumstances, the inventors of the present invention have conducted earnest research to solve the drawbacks of the conventional method for preserving cells in urine, and as a result, it was confirmed that the cells of It was found that metabolism can be suppressed, autodigestion can be suppressed, and bacterial reproduction and metabolism can be suppressed at the same time. Furthermore, it was discovered that the addition of EDTA.2Na (ethylenediaminetetraacetic acid disodium salt) significantly inhibits the metabolism and growth of Gram-negative bacteria often contained in urine due to its antibacterial effect. It is what you have done.

すなわち本発明は尿中の細胞を計測及び診断する際にク
エン酸などpHを酸性に保持しうる緩衝剤と、0.4〜4.0mg
/ml(尿あたり)のEDTA・2Na(エチレンジアミンテトラ
アセチックアシド2ナトリウム塩)とを、採取した試料
尿に添加してpHを4.5〜6.5に調整する尿中の細胞保存方
法である。
That is, the present invention is a buffer that can keep the pH acidic such as citric acid when measuring and diagnosing cells in urine, 0.4 ~ 4.0 mg
This is a method for preserving cells in urine by adding / ml (per urine) EDTA · 2Na (ethylenediaminetetraacetic acid disodium salt) to the collected sample urine to adjust the pH to 4.5 to 6.5.

尿中に生体から剥離あるいは漏出した生体細胞は代謝を
継続して行っており,低栄養時には細胞内の食作用空泡
で自己を消化して代謝に必要な栄養補給を行い,それに
より自己融解を起こすことは知られている(「細胞生物
学」J.カープ著,寺山宏他共訳,東京大学出版会発行.1
987.3.25参照)。又これら細胞の代謝系の酵素群は解糖
系,クエン酸回路系,脂肪代謝,アミノ酸分解系等の殆
どで最適なpHが6.5以上であり,これより酸性の環境で
は代謝が抑制されることも知られている(「ストライヤ
ーの生化学」田宮信雄他訳,東京化学同人,1977.3.22及
び「臨床酵素ハンドブック」馬場茂明他編纂,講談社,1
981.9.10参照)。又例えば「微生物検査必携」厚生省監
修(1961.3.25日本公衆衛生協会発行)にあるように,
一般に環境として細菌の増殖に最適のpHは殆どの場合6.
5以上であり,これより酸性となると増殖が抑制される
ことは公知であり,グラム陰性菌がEDTAによって細胞外
膜が破壊され,菌の代謝,増殖機能が停止さることも公
知となっている(C.A.Schnaitman.「Effect of Ethylen
ediamine tetraacetic Acid,Trito X−100,and Lysozym
e on the Morphology and Chemical Composition of Is
olated Cell Walls of Esherichiacoli」,Jour.of Bact
eriology,Vol.108,p553〜563,1971参照)。しかしなが
らこれらは一般的な知識であって試料尿を酸性にした場
合の細胞及び細菌の代謝,増殖抑制に対する即効性や尿
に酸を加えて酸性に保持することによって尿中の生体細
胞を保存する方法については何も示唆するところはな
い。
Living cells that have been exfoliated or leaked from the living body in the urine continue to be metabolized, and during malnutrition, phagocytic bubbles in the cells digest themselves to provide the nutrients necessary for metabolism, which results in autolysis. It is known to cause (cell biology, J. Carp, co-translated by Hiroshi Terayama et al., Published by The University of Tokyo Press. 1
See 987.3.25). In addition, most of the metabolic enzymes in these cells, such as glycolysis, citric acid cycle system, fat metabolism, amino acid decomposition system, have an optimum pH of 6.5 or higher, and metabolism is suppressed in an acidic environment. Also known ("Biochemistry of Stryer" translated by Nobuo Tamiya, Tokyo Kagaku Dojin, 1977.3.22 and "Clinical Enzyme Handbook" edited by Shigeaki Baba et al., Kodansha, 1
981.9.10). Also, for example, as "Indispensable for microbiological testing" supervised by the Ministry of Health and Welfare (1961.3.25 published by Japan Public Health Association)
In general, the optimum pH for bacterial growth in most cases is 6.
It is well-known that the growth is suppressed when it is more than 5 and more acidic than this, and it is also known that the extracellular membrane of gram-negative bacteria is destroyed by EDTA and the metabolism and growth functions of the bacteria are stopped. (CASchnaitman. "Effect of Ethylen
ediamine tetraacetic Acid, Trito X−100, and Lysozym
e on the Morphology and Chemical Composition of Is
`` Olated Cell Walls of Esherichiacoli '', Jour. of Bact
eriology, Vol. 108, p553 to 563, 1971). However, these are general knowledge, and when the sample urine is acidified, it has immediate effect on the metabolism and growth inhibition of cells and bacteria, and it preserves living cells in urine by adding acid to urine and keeping it acidic. There is no suggestion on how to do it.

尿のpHは通常4.5〜10.0と広い範囲であるが,本発明で
は酸を緩衝剤として加えてpHを4.5〜6.5になるように調
整する。
The pH of urine is usually in a wide range of 4.5 to 10.0, but in the present invention, acid is added as a buffer to adjust the pH to 4.5 to 6.5.

この発明に用いる酸は無機酸,有機酸いずれでも良い。
しかし有機酸で粉末状となり試料採取管に一定量を予め
入れておいて,採取管に尿を採取すると自動的に尿と混
合して容易に適当なpHとなるようにできるものが好まし
い。
The acid used in this invention may be either an inorganic acid or an organic acid.
However, it is preferable to use a powder which is made into a powder with an organic acid and which is put into a sampling tube in advance, and when urine is sampled in the sampling tube, the urine is automatically mixed with the urine so that an appropriate pH can be easily obtained.

特にクエン酸を1.0〜4.0mg/ml(尿当たり)用いると尿
のpHは4.5〜6.5となるので便利である。さらにこれにED
TA・2Naを併用すると尿中の細胞の保存効果が向上す
る。EDTA・2Naは0.4〜4.0mg/ml(尿当たり)の量で実効
を有するものである。
Especially, it is convenient to use citric acid at 1.0 to 4.0 mg / ml (per urine) because the pH of urine becomes 4.5 to 6.5. ED to this
The combined use of TA and 2Na improves the effect of preserving cells in urine. EDTA · 2Na is effective in an amount of 0.4 to 4.0 mg / ml (per urine).

本発明を実施するには,例えば尿を10〜30ml入れる容量
の採取管にクエン酸及びEDTA・2Naを主体とする水溶液
を尿に混合した時に前記の濃度(pH)となる量だけ入れ
て,何らかの方法で水分を蒸発させて成分を粉末状と
し,採取管の底部に付着させる。この採取管に尿を10〜
30ml採取してそのまま保存して細胞の計測及び診断を行
えばよい。
In order to carry out the present invention, for example, an amount of the above-mentioned concentration (pH) when urine is mixed with an aqueous solution mainly containing citric acid and EDTA · 2Na is put into a collection tube having a volume of 10 to 30 ml of urine, Moisture is evaporated by some method to make the components powdery and attached to the bottom of the sampling tube. Urine 10 ~
30 ml may be collected and stored as it is for cell measurement and diagnosis.

「実施例」 実施例1。"Example" Example 1.

試料採取管に尿を採取してクエン酸4mg/ml(尿あたり)
を添加して混合した。尿のpHは6.8であり,添加後はpH
は4.5となった。
Collect urine in a sampling tube to collect citric acid 4 mg / ml (per urine)
Was added and mixed. Urine has a pH of 6.8, and after addition
Was 4.5.

この尿試料を25℃に保持して12時間毎の細胞数を測定
し,また細胞を顕微鏡で観察して細胞の変性を前述の判
定度数を用いて評価したところ,24時間後まで変化が起
こらなかった。48時間後には細胞数は8%低下し,判定
度数は3まで低下した。
This urine sample was kept at 25 ° C, the number of cells was measured every 12 hours, and the cells were observed under a microscope to evaluate the degeneration of the cells using the above-mentioned judgment frequency. There wasn't. After 48 hours, the number of cells decreased by 8% and the judgment frequency decreased to 3.

実施例2。Example 2.

実施例1と同様にしてクエン酸4mg/ml(尿あたり)及び
EDTA・2Naを3mg/ml(尿あたり)となるようにクエン酸
とEDTA・2Naを添加して混合した。用いた試料尿のpHは
6.8であり,添加後にはpHは5.4となった。
Citric acid 4 mg / ml (per urine) and as in Example 1
Citric acid and EDTA · 2Na were added and mixed so that EDTA · 2Na was 3 mg / ml (per urine). The pH of the sample urine used is
The pH was 6.8, and the pH became 5.4 after the addition.

この試料を25℃に保持して12時間毎の細胞数を測定し,
また顕微鏡で細胞を観察して判定度数を評価したとこ
ろ,24時間後まで変化がなかった。48時間後では細胞数
は5%低下し,判定度数は4まで低下した。
Hold this sample at 25 ℃ and measure the number of cells every 12 hours.
When the cells were observed with a microscope and the judgment frequency was evaluated, there was no change until 24 hours later. After 48 hours, the number of cells decreased by 5% and the judgment frequency decreased to 4.

実施例3。Example 3.

実施例1と同様にして1規定の塩酸20μ/ml EDTA・2N
aを3mg/ml(尿あたり)を添加して混合した。尿のpHは
6.8であり,添加後にはpHは5.4となった。
In the same manner as in Example 1, 1N hydrochloric acid 20 μ / ml EDTA · 2N
3 mg / ml (per urine) of a was added and mixed. The pH of urine
The pH was 6.8, and the pH became 5.4 after the addition.

この試料を25℃に保持して12時間毎の細胞数を測定し,
また顕微鏡で細胞を観察して判定度数を評価したとこ
ろ,24時間後まで変化しないことが分かった。48時間後
では細胞数は5%低下し,判定度数は4まで低下した。
Hold this sample at 25 ℃ and measure the number of cells every 12 hours.
Moreover, when the cells were observed with a microscope and the judgment frequency was evaluated, it was found that there was no change until 24 hours later. After 48 hours, the number of cells decreased by 5% and the judgment frequency decreased to 4.

「発明の効果」 以上に詳しく説明したように本発明は尿中の細胞を計
測,診断する際に,採取尿試料に緩衝剤として酸,特に
クエン酸を添加して尿のpHを4.5〜6.5に調整するだけで
試料尿中での細胞の数及び変性を防止することができる
ので,試料尿採取後の計測,診断までに数十時間保存し
ても正確な計測値と診断が得られるものであり,尿中の
生体細胞,例えば血液細胞等の数の計測検査,細胞診断
検査に用いて有効なものであり,特に大量の試料を検査
する場合等に非常に有効な方法である。
"Effects of the Invention" As described in detail above, the present invention adjusts the pH of urine to 4.5 to 6.5 by adding an acid, particularly citric acid, as a buffer to a collected urine sample when measuring and diagnosing cells in urine. The number and denaturation of the cells in the sample urine can be prevented simply by adjusting the value to 1. Therefore, accurate measurement values and diagnosis can be obtained even if the cells are stored for tens of hours before measurement and diagnosis after sample urine collection. It is effective for measuring the number of living cells in urine, such as blood cells, and for cytodiagnostic test, and is a very effective method especially when testing a large amount of sample.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】尿中の細胞を計測或いは診断する際に、 クエン酸などpHを酸性に保持しうる緩衝剤と、0.4〜4.0
mg/ml(尿あたり)のEDTA・2Na(エチレンジアミンテト
ラアセチックアシド2ナトリウム塩)とを、採取した試
料尿に添加してpHを4.5〜6.5に調整することを特徴とす
る尿中の細胞保存方法。
1. When measuring or diagnosing cells in urine, a buffering agent such as citric acid which can keep pH at an acidic level, and 0.4 to 4.0.
Cell preservation in urine, characterized by adding mg / ml (per urine) of EDTA.2Na (ethylenediaminetetraacetic acid disodium salt) to the collected sample urine to adjust the pH to 4.5 to 6.5 Method.
【請求項2】前記緩衝剤は、0.4〜4.0mg/ml(尿あた
り)のクエン酸であることを特徴とする請求項1に記載
の尿中の細胞保存方法。
2. The method for preserving cells in urine according to claim 1, wherein the buffer is 0.4 to 4.0 mg / ml (per urine) of citric acid.
JP2090638A 1990-04-04 1990-04-04 Method for preserving cells in urine Expired - Lifetime JPH0778502B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2090638A JPH0778502B2 (en) 1990-04-04 1990-04-04 Method for preserving cells in urine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2090638A JPH0778502B2 (en) 1990-04-04 1990-04-04 Method for preserving cells in urine

Publications (2)

Publication Number Publication Date
JPH04118557A JPH04118557A (en) 1992-04-20
JPH0778502B2 true JPH0778502B2 (en) 1995-08-23

Family

ID=14004042

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2090638A Expired - Lifetime JPH0778502B2 (en) 1990-04-04 1990-04-04 Method for preserving cells in urine

Country Status (1)

Country Link
JP (1) JPH0778502B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2681244B2 (en) * 1993-01-18 1997-11-26 株式会社いかがく Analytical method for urinary dissolved components
US7029840B2 (en) * 2000-11-15 2006-04-18 Becton, Dickinson And Company Method for preservation of cells and nucleic acid targets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5033031A (en) * 1973-07-30 1975-03-31
JPS6047960A (en) * 1983-08-26 1985-03-15 Wako Pure Chem Ind Ltd Staining method and staining test solution of cell in cytology

Also Published As

Publication number Publication date
JPH04118557A (en) 1992-04-20

Similar Documents

Publication Publication Date Title
JP3723494B2 (en) Cell preservation solution
Kusumi et al. Rapid detection of pyuria by leukocyte esterase activity
Fair et al. Prostatic antibacterial factor identity and significance
Vass et al. Decomposition chemistry of human remains: a new methodology for determining the postmortem interval
AU669673B2 (en) Methods and compositions with aldehyde stabilizing solution
Ogg et al. The C'3 component of complement (β1c-globulin) in patients with heavy proteinuria
CA2439830A1 (en) Determining the risk of caries in a patient
Alexander et al. Urinary ethanol and diabetes mellitus
Hatfield et al. Threonine Deaminase from Bacillus subtilis: I. PURIFICATION OF THE ENZYME
AU655594B2 (en) Very rapid detection of fungal infections
US9410179B2 (en) Diagnostic method for the determination of Helicobacter pylori
Johnston et al. An automated test for the detection of significant bacteriuria
JPH0778502B2 (en) Method for preserving cells in urine
US4330622A (en) Elimination of non-microbial turbidity in culture media
CN111134109A (en) Urine single cell preservation solution and preparation method thereof
Chanarin et al. Estimation of serum L. casei activity
Cho et al. Prediction of cadaver kidney function by ligandin analysis
US20220287295A1 (en) Use of annelid haemoglobin in vitro
CN105164271B (en) Measure method existing for antibiotic in fluid
JP2681244B2 (en) Analytical method for urinary dissolved components
Starr et al. Coronary perfusate composition influences diastolic properties, myocardial water content, and histologic characteristics of the rat left ventricle
JP2603576B2 (en) How to save cells in urine
JP4848555B2 (en) Preservative composition for urine
Zaneveld et al. Biochemical analysis of seminal plasma and spermatozoa
Allen et al. Membrane transport of amino acid enantiomers in protoscoleces of Echinococcus granulosus (Cestoda)

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080823

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080823

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090823

Year of fee payment: 14

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100823

Year of fee payment: 15

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100823

Year of fee payment: 15